• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数保留的心力衰竭患者肾功能障碍的临床特征及预后影响。

Clinical characteristics and prognostic influence of renal dysfunction in heart failure patients with preserved ejection fraction.

机构信息

Internal Medicine Service, Hospital Universitario del Henares, Madrid, Spain.

出版信息

Eur J Intern Med. 2013 Oct;24(7):677-83. doi: 10.1016/j.ejim.2013.06.003. Epub 2013 Jul 3.

DOI:10.1016/j.ejim.2013.06.003
PMID:23830876
Abstract

BACKGROUND

Renal dysfunction is common in patients with heart failure (HF) and is associated with high mortality. This relationship is well established in HF and reduced ejection fraction (HFREF), however, it is not fully understood in HF and preserved ejection fraction (HFPEF). The aim of this study was to determine the impact of renal dysfunction on all-cause mortality in HFPEF patients and to evaluate the clinical characteristics of patients that deteriorate renal function in the first year of follow-up.

METHODS

We evaluated the patients with HFPEF included in the RICA registry. This is a multi-center and prospective cohort study that includes patients admitted for decompensated HF. Estimated glomerular filtration rate (eGFR), blood urea nitrogen (BUN) and plasma creatinine concentrations were used for renal function assessment at admission and after one year of follow up.

RESULTS

A total of 455 patients (mean age 78±8.1years; 62% women) were included, of whom 265 (58.2%) had eGFR<60mL/min/1.73m(2). After adjustment for covariates, only lower admission eGFR remained significantly predictive of all-cause mortality (HR 2.97; 95% CI 1.59-5.53). After one year of follow-up 16.6% of patients deteriorated at least 25% of eGFR. These patients were more likely to be diabetic (54.5% vs 42.6%; p=0.039) and had a higher rate of prescription of mineralcorticoid receptor antagonist (MRA) agents (47% vs 23.3%; p<0.001).

CONCLUSION

Renal dysfunction is frequently associated with HFPEF. eGFR below normal is strongly associated with mortality. Further decline of renal function is frequent especially among diabetic and patients treated with MRA agents.

摘要

背景

肾功能障碍在心力衰竭(HF)患者中很常见,与高死亡率相关。这种关系在射血分数降低的心力衰竭(HFREF)中已经得到很好的证实,但在射血分数保留的心力衰竭(HFPEF)中尚未完全了解。本研究旨在确定肾功能障碍对 HFPEF 患者全因死亡率的影响,并评估在随访的第一年肾功能恶化的患者的临床特征。

方法

我们评估了 RICA 登记处纳入的 HFPEF 患者。这是一项多中心前瞻性队列研究,包括因失代偿性 HF 入院的患者。在入院时和随访一年后,使用估算肾小球滤过率(eGFR)、血尿素氮(BUN)和血浆肌酐浓度评估肾功能。

结果

共纳入 455 例患者(平均年龄 78±8.1 岁;62%为女性),其中 265 例(58.2%)eGFR<60mL/min/1.73m(2)。在校正了混杂因素后,只有较低的入院 eGFR 仍然与全因死亡率显著相关(HR 2.97;95%CI 1.59-5.53)。在随访一年后,16.6%的患者 eGFR 至少下降了 25%。这些患者更有可能患有糖尿病(54.5%比 42.6%;p=0.039),并且更有可能开处方使用盐皮质激素受体拮抗剂(MRA)药物(47%比 23.3%;p<0.001)。

结论

肾功能障碍在 HFPEF 中很常见。正常以下的 eGFR 与死亡率密切相关。肾功能进一步下降很常见,尤其是在糖尿病和接受 MRA 药物治疗的患者中。

相似文献

1
Clinical characteristics and prognostic influence of renal dysfunction in heart failure patients with preserved ejection fraction.射血分数保留的心力衰竭患者肾功能障碍的临床特征及预后影响。
Eur J Intern Med. 2013 Oct;24(7):677-83. doi: 10.1016/j.ejim.2013.06.003. Epub 2013 Jul 3.
2
Influence of renal dysfunction phenotype on mortality in decompensated heart failure with preserved and mid-range ejection fraction.肾功能不全表型对射血分数保留及射血分数中度降低的失代偿性心力衰竭患者死亡率的影响。
Int J Cardiol. 2017 Sep 15;243:332-339. doi: 10.1016/j.ijcard.2017.05.048. Epub 2017 May 12.
3
Renal dysfunction in patients with heart failure with preserved versus reduced ejection fraction: impact of the new Chronic Kidney Disease-Epidemiology Collaboration Group formula.心力衰竭射血分数保留与降低患者的肾功能障碍:新慢性肾脏病-流行病学协作组公式的影响。
Circ Heart Fail. 2012 May 1;5(3):309-14. doi: 10.1161/CIRCHEARTFAILURE.111.966242. Epub 2012 Mar 22.
4
Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions.心力衰竭伴射血分数保留和降低的门诊患者低钠血症的预后意义。
Am J Cardiol. 2014 Jun 1;113(11):1834-8. doi: 10.1016/j.amjcard.2014.03.017. Epub 2014 Mar 18.
5
Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.医疗保险人群中心力衰竭伴射血分数保留、中间值和降低患者的结局。
Am Heart J. 2014 Nov;168(5):721-30. doi: 10.1016/j.ahj.2014.07.008. Epub 2014 Jul 22.
6
In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.根据临床表现(新发与恶化)和射血分数划分的急性心力衰竭患者的院内及1年预后。来自IN-HF结局登记研究的结果
Int J Cardiol. 2014 May 1;173(2):163-9. doi: 10.1016/j.ijcard.2014.02.018. Epub 2014 Feb 22.
7
Prognostic value of glomerular filtration rate estimation equations in acute heart failure with preserved versus reduced ejection fraction.射血分数保留与降低的急性心力衰竭中肾小球滤过率估算方程的预后价值
Int J Clin Pract. 2015 Aug;69(8):829-39. doi: 10.1111/ijcp.12616. Epub 2015 Feb 4.
8
Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.心力衰竭伴保留、中间范围和射血分数降低患者中慢性肾脏病的相关性及其预后影响。
Eur J Heart Fail. 2017 Dec;19(12):1606-1614. doi: 10.1002/ejhf.821. Epub 2017 Mar 29.
9
Differential impact of heart rate and blood pressure on outcome in patients with heart failure with reduced versus preserved left ventricular ejection fraction.心率和血压对射血分数降低型与射血分数保留型心力衰竭患者结局的影响差异。
Int J Cardiol. 2012 Mar 8;155(2):249-56. doi: 10.1016/j.ijcard.2010.10.007. Epub 2010 Oct 28.
10
Comparison of characteristics and outcomes of patients with heart failure preserved ejection fraction versus reduced left ventricular ejection fraction in an urban cohort.比较城市队列中射血分数保留型心力衰竭与射血分数降低型心力衰竭患者的特征和结局。
Am J Cardiol. 2014 Feb 15;113(4):691-6. doi: 10.1016/j.amjcard.2013.11.014. Epub 2013 Nov 23.

引用本文的文献

1
AI hybrid survival assessment for advanced heart failure patients with renal dysfunction.用于肾功能不全的晚期心力衰竭患者的人工智能混合生存评估
Nat Commun. 2024 Aug 8;15(1):6756. doi: 10.1038/s41467-024-50415-9.
2
Clinical profile and contemporary management of patients with heart failure with preserved ejection fraction: results from the CHECK-HF registry.射血分数保留的心力衰竭患者的临床特征与当代治疗:CHECK-HF注册研究结果
Neth Heart J. 2021 Jul;29(7-8):370-376. doi: 10.1007/s12471-020-01534-7. Epub 2021 Jan 13.
3
Beyond the myocardium? SGLT2 inhibitors target peripheral components of reduced oxygen flux in the diabetic patient with heart failure with preserved ejection fraction.
超越心肌?SGLT2 抑制剂针对心力衰竭伴射血分数保留的糖尿病患者减少的氧流量的外周成分。
Heart Fail Rev. 2022 Jan;27(1):219-234. doi: 10.1007/s10741-020-09996-y.
4
The profile of selected single nucleotide polymorphisms in patients with hypertension and heart failure with preserved and mid-range ejection fraction.高血压伴射血分数保留和中间范围心力衰竭患者中选定单核苷酸多态性的特征。
Sci Rep. 2017 Aug 21;7(1):8974. doi: 10.1038/s41598-017-09564-9.
5
Heart failure with preserved ejection fraction: a nephrologist-directed primer.射血分数保留的心力衰竭:肾脏病专家指导概要。
Heart Fail Rev. 2017 Nov;22(6):765-773. doi: 10.1007/s10741-017-9619-2.